Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension

Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study

(2022) Cecilia Berardi et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Malignant Hypertension: Current Perspectives and Challenges

(2022) Romain Boulestreau et al.   Journal of the American Heart Association

Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia

(2021) Theresa M. Wewers et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID‐19 patients

(2021) Bérangère S. Joly et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical value of multiorgan damage in hypertensive crises: A prospective follow‐up study

(2020) Hongkun Ma et al.   Journal of Clinical Hypertension

Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria

(2020) Eikan Mishima et al.   HYPERTENSION RESEARCH

Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia

(2019) Luigi Raio et al.   JOURNAL OF HYPERTENSION

Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

(2019) Teresa Cavero et al.   KIDNEY INTERNATIONAL

Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency

(2017) Ang Li et al.   TRANSFUSION

Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura

(2016) M. Le Besnerais et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Soluble Flt-1 links microvascular disease with heart failure in CKD

(2015) Giovana S. Di Marco et al.   BASIC RESEARCH IN CARDIOLOGY

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy

(2015) L. Erpenbeck et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

(2014) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Vascular endothelial growth factor and the kidney

(2013) Andrew Advani   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Obstetric Nephrology: AKI and Thrombotic Microangiopathies in Pregnancy

(2012) F. Fakhouri et al.   Clinical Journal of the American Society of Nephrology

ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome

(2011) S. Yang et al.   HAEMATOLOGICA

Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension

(2011) Alena Shantsila et al.   HYPERTENSION

Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension

(2011) Vahid Mohsenin et al.   RESPIRATORY MEDICINE

Vascular Endothelial Growth Factor, Soluble Fms-Like Tyrosine Kinase 1, and the Severity of Coronary Artery Disease

(2010) Soo-Young Kim et al.   ANGIOLOGY

Impact of malignant arterial hypertension on the heart

(2010) Philippe Gosse et al.   JOURNAL OF HYPERTENSION

Long-term renal survival in malignant hypertension

(2010) R. Gonzalez et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A PROSPECTIVE, OBSERVATIONAL STUDY OF SOLUBLE FLT-1 AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEPSIS

(2009) Nathan I. Shapiro et al.   SHOCK

Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant Hypertension

(2008) Bert-Jan H. van den Born et al.   HYPERTENSION